Home › fda
 

Keywords :   


Tag: fda

FDA to Hold Public Workshop on Pilot Projects

2016-02-16 09:00:00| Expeditors Newsflash - Americas Edition

Expeditors Newsflash - Americas Edition

Tags: public hold projects workshop

 

Merck Receives Complete Response Letter from the U.S. FDA for ZETIA (ezetimibe) and VYTORIN (ezetimibe and simvastatin)

2016-02-15 23:30:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding Merck's Supplemental New Drug Applications for ZETIA and VYTORIN for the reduction of the risk of cardiovascular events (cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, hospitalization for unstable angina, or need for revascularization) in patients with coronary heart disease. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558orMichael Close, 267-305-1211orInvestors:Amy Klug, 908-740-1898orTeri Loxam, 908-740-1986 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: complete response letter receives

 
 

FDA Seeks $5.1 Billion for 2017 Food Safety, Medical and Quality Improvements

2016-02-10 18:17:00| Food Processing

The FDA is requesting a total budget of $5.1 billion to protect and promote the public health as part of the Presidents fiscal year 2017 budget an eight-percent boost over FY 2016.

Tags: quality food medical safety

 

US FDA Seeks 8% Increase in Budget

2016-02-09 06:00:00| Happi Breaking News

A request for $5.1 billion for fiscal year 2017.

Tags: increase budget seeks fda

 

Sangamo Announces FDA Clearance Of Investigational New Drug Application

2016-02-09 03:38:16| drugdiscoveryonline News Articles

Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for SB-318, a single treatment strategy intended to provide a life-long therapy for Mucopolysaccharidosis Type I (MPS I).

Tags: application drug clearance announces

 

Sites : [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] next »